|
|
|
The Permission for Clinical Trial for Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection was issued 2017-02-01 10:35 |
|
|
|
“Recombinant Anti-VEGF Humanized Monoclonal Antibody Injection” was approved to conduct clinical trial by CFDA on 23rd, January in 2017. |
|
|
|
|
|
|
|
| Links | SiteMap | Privacy |
Copyright© Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 2007 |
|
|
|
|
沪公网安备31011502002670号 (沪)-非经营性-2024-0273 沪ICP备10027510号-1 |
|
|